- Home
- MBAI vs PAVM Comparison
MBAI vs PAVM Comparison
Compare MBAI & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBAI | PAVM |
|---|---|---|
| Founded | 2004 | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.1M | 41.1M |
| IPO Year | 2014 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MBAI | PAVM |
|---|---|---|
| Price | $2.29 | $1.64 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | ★ 24.4K | 9.2K |
| Earning Date | 11-20-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,000,000.00 |
| Revenue This Year | $103.86 | $132.39 |
| Revenue Next Year | $231.30 | $263.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $0.95 | $0.21 |
| 52 Week High | $10.21 | $43.99 |
Technical Indicators
Market Signals| Indicator | MBAI | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 40.92 | 25.30 |
| Support Level | $1.33 | N/A |
| Resistance Level | $2.64 | $6.56 |
| Average True Range (ATR) | 0.25 | 0.20 |
| MACD | 0.14 | 0.02 |
| Stochastic Oscillator | 65.55 | 15.92 |
Price Performance
Historical ComparisonAbout MBAI Check-Cap Ltd. Ordinary Share
MBody AI Ltd develops enterprise software to deploy and manage autonomous robot workforces for hospitality and gaming operators. The Company's proprietary MBody AI Orchestrator is a hardware-agnostic software platform that manages diverse robot fleets from multiple vendors across sites and use cases under long-term agreements. MBody AI serves Fortune 500 operators as customers.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.